UCLA Beverly Hills is a clinical research site located in Beverly Hills, California, United States 90212.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
UCLA Beverly Hills has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Early Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCLA Beverly Hills has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Beverly Hills has 1 clinical trials on record, with 1 currently active. Their work covers Early Breast Cancer.
UCLA Beverly Hills has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.